BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

979 related articles for article (PubMed ID: 30935420)

  • 1. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Li W; Fu Z
    World J Surg Oncol; 2019 Apr; 17(1):60. PubMed ID: 30935420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
    Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
    Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis.
    Zhang JZ; Wu ZH; Cheng Q
    Medicine (Baltimore); 2019 Nov; 98(48):e17997. PubMed ID: 31770211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of candidate genes of nasopharyngeal carcinoma by bioinformatical analysis.
    Ye Z; Wang F; Yan F; Wang L; Li B; Liu T; Hu F; Jiang M; Fu Z
    Arch Oral Biol; 2019 Oct; 106():104478. PubMed ID: 31319350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening Key Genes and Biological Pathways in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis.
    Tai J; Park J; Han M; Kim TH
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.
    Wang Y; Li M; Guo Y; Huang H; Dong X; Sun Y; Liu J
    Aging (Albany NY); 2021 Sep; 13(18):22176-22187. PubMed ID: 34544905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma.
    Liu J; Li X; Yang S; Mou J; Lu H
    Pathol Res Pract; 2020 Dec; 216(12):153244. PubMed ID: 33113455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray Analysis of Novel Genes Involved in Nasopharyngeal Carcinoma.
    Wang B; Wang W; Wang H; Liu W
    Bull Exp Biol Med; 2021 Mar; 170(5):658-664. PubMed ID: 33788105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
    Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
    Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis.
    Mi JL; Xu M; Liu C; Wang RS
    Medicine (Baltimore); 2020 Aug; 99(32):e21505. PubMed ID: 32769887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis.
    Zou Z; Gan S; Liu S; Li R; Huang J
    Oncol Lett; 2019 Jul; 18(1):916-926. PubMed ID: 31289570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma.
    Yue H; Zhu H; Luo D; Du Q; Xie Y; Huang S; Liu W
    Comput Math Methods Med; 2022; 2022():1941412. PubMed ID: 35509856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.